Mycoplasma hyopneumoniae: From disease to vaccine development
Authors:
- 1 August 2013
- journal article
- review article
- Published by Elsevier in Veterinary Microbiology
- Vol. 165 (3-4) , 234-242
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Sequence TTKF↓QE Defines the Site of Proteolytic Cleavage in Mhp683 Protein, a Novel Glycosaminoglycan and Cilium Adhesin of Mycoplasma hyopneumoniaeJournal of Biological Chemistry, 2011
- The central role of lipoproteins in the pathogenesis of mycoplasmosesVeterinary Microbiology, 2011
- Evaluation of immune response to recombinant potential protective antigens of Mycoplasma hyopneumoniae delivered as cocktail DNA and/or recombinant protein vaccines in miceVaccine, 2008
- Protein variability among Mycoplasma hyopneumoniae isolatesVeterinary Microbiology, 2007
- Evaluation of the immunogenicity of the P97R1 adhesin of Mycoplasma hyopneumoniae as a mucosal vaccine in miceJournal of Medical Microbiology, 2006
- Comparative immunogenicity of M. hyopneumoniae NrdF encoded in different expression systems delivered orally via attenuated S. typhimurium aroA in miceVeterinary Microbiology, 2006
- In Vivo Expression Analysis of the P97 and P102 Paralog Families of Mycoplasma hyopneumoniaeInfection and Immunity, 2005
- Expression and Immunogenicity ofMycoplasma hyopneumoniaeHeat Shock Protein Antigen P42 by DNA VaccinationInfection and Immunity, 2003
- A recombinant chimera composed of repeat region RR1 of Mycoplasma hyopneumoniae adhesin with Pseudomonas exotoxin: in vivo evaluation of specific IgG response in mice and pigsVeterinary Microbiology, 2001
- Application of a Nested Polymerase Chain Reaction Assay to DetectMycoplasma Hyopneumoniaefrom Nasal SwabsJournal of Veterinary Diagnostic Investigation, 1999